海外の治験の状況「1」での検索結果
7748件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- RIBOGENE: Optimisation of Riboflavin Status in Hypertensive Adults With a Genetic Predisposition to Elevated Blood Pressure
- Participants With the MTHFR 677TT Genotype
- United Kingdom
- 2015-06-02
Not recruiting
- A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects
- Bacterial Enteritis;Bacterial Enteritis;Bacterial Enteritis;Bacterial Enteritis
- United Kingdom
- 2015-05-01
Not Recruiting
- Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment with Ingenol Mebutate Gel, 0.05% A phase 1 trial A multi-centre, single arm, open-label, 8-week trial ICH
- ;L57.0 - Actinic keratosis
- Australia, Germany
- 2015-04-29
Not recruiting
- Validation of the 1-minute Sit-to-stand Test in Patients With COPD
- Pulmonary Disease, Chronic Obstructive
- Switzerland
- 2015-04-29
Not recruiting
- Platelet Rich Fibrin in the Treatment of Palatal Wounds
- Gingival Recession
- Italy
- 2015-04-27
Not Recruiting
- A Multi-center, Longitudinal, Observational Study of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) to Establish the Rate, Characteristics, and Determinants of Disease Progression
- Autosomal Dominant Polycystic Kidney Disease (ADPKD);Q61.2 - Polycystic kidney, autosomal dominant
- Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, France, Germany, Italy, Japan, Netherlands, Norway, Poland, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States
- 2015-03-26
Not Recruiting
- Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
- IgA Nephropathy;N02.8 - Recurrent and persistent haematuria; Other
- Germany
- 2015-03-10
Not recruiting
- Clinical Evaluation of MyDay™ and 1-DAY ACUVUE® TruEye®
- Refractive Error;Refractive Error;Refractive Error;Refractive Error
- United Kingdom, United States
- 2015-03-10
Not recruiting
- Extension Study of MT-1303 in Subjects With Crohn's Disease
- Crohn's Disease;Crohn's Disease;Crohn's Disease;Crohn's Disease
- Czech Republic, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Netherlands, Poland, Slovakia, Ukraine
- 2015-03-10
Not recruiting
- Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia
- Androgenetic Alopecia;Alopecia;Hair Loss
- Spain
- 2015-03-03
Not recruiting
- Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease
- Crohn's Disease;Crohn's Disease
- Czech Republic, France, Germany, Hungary, Israel, Italy, Japan, Netherlands, Poland, Slovakia, Ukraine
- 2015-02-27
Not recruiting
- Eating Behaviour in Crohn's Disease
- Crohn's Disease;Crohn's Disease;Crohn's Disease
- United Kingdom
- 2015-02-26
Not Recruiting
- A Phase 1 study of anti-HER3 monoclonal antibody GSK2849330, in subjects with advanced HER3-positive solid tumors.
- Subjects with advanced HER3-positive solid tumors MedDRA version: 17.1 Level: PT Classification code 10017758 Term: Gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: LLT Classification code 10033575 Term: Pancreas cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: LLT Classification code 10053571 Term: Melanoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: PT Classification code 10073071 Term: Hepatocellular carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: LLT Classification code 10008229 Term: Cervical cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: PT Classification code 10005003 Term: Bladder cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: PT Classification code 10061873 Term: Non-small cell lung cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: PT Classification code 10061451 Term: Colorectal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: PT Classification code 10006187 Term: Breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: PT Classification code 10033128 Term: Ovaria;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Netherlands, United States
- 2015-02-12
Not recruiting
- Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With Immunoglobulin A Nephropathy on Stable RAAS Blockade
- Immunoglobulin A Nephropathy
- Sweden, United States
- 2015-02-11
Not recruiting
- GM-CSF to Decrease ICU Acquired Infections
- Septic Shock;Severe Sepsis
- France
- 2015-02-06
Not recruiting
- A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH
- Paroxysmal Nocturnal Hemoglobinuria (PNH);Paroxysmal Nocturnal Hemoglobinuria (PNH);Paroxysmal Nocturnal Hemoglobinuria (PNH);Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Spain, United Kingdom
- 2015-01-23
Not Recruiting
- A randomized, double-blind, study of ruxolitinib or placebo in combination with capecitabine as second line treatent for Subjects With Pancreatic cancer (The JANUS 1 Study)
- Male or female, 18 years or older with histologically or cytologically confirmed adenocarcinoma of the pancreas that is inoperable or metastatic. MedDRA version: 17.0 Level: LLT Classification code 10033606 Term: Pancreatic cancer non-resectable System Organ Class: 100000004864 MedDRA version: 17.0 Level: LLT Classification code 10033605 Term: Pancreatic cancer metastatic System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, European Union, Italy, Korea, Republic of, New Zealand, Spain, Taiwan, Thailand, United Kingdom, United States
- 2014-06-23
Not recruiting
- Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)
- Colorectal Neoplasms;Colorectal Neoplasms;Colorectal Neoplasms;Colorectal Neoplasms
- Argentina, Australia, Austria, Belgium, Canada, Czech Republic, Czechia, Denmark, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Republic of, Luxembourg, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Taiwan, Turkey, United Kingdom, United States
- 2014-05-26
Not Recruiting
- Study to evaluate 2 types of treatment (masitinib + FOLFIRI or placebo + FOLFIRI) in the treatment of patients with metastatic colorectal cancer that have received 1 previous therapy
- Metastatic colorectal cancer after 1 previous line of treatment br>MedDRA version: 18.0 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Canada, China, Cyprus, Czech Republic, Egypt, France, Greece, Hong Kong, Hungary, India, Israel, Italy, Korea, Republic of, Lebanon, Malaysia, Mexico, Morocco, Myanmar, Peru, Philippines, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Taiwan, Tunisia, Ukraine, United Kingdom, United States
- 2014-01-30
Not recruiting
- Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
- Alopecia, Androgenetic;Alopecia, Androgenetic;Alopecia, Androgenetic
- Belgium, Germany, Hungary, Russian Federation, Spain
- 2016-12-23
